Trials / Unknown
UnknownNCT03871062
Study of Two-step Anesthesia in Intravitreal Injection
A Prospective, Randomised, Single-masked Comparison of Topical Anesthesia and Topical Combined Subconjunctival (Two-step) Anesthesia in Intravitreal Injection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Aier School of Ophthalmology, Central South University · Academic / Other
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, randomised, single-masked comparison of local anaesthetic approaches including topical anesthesia combined sub-conjunctival anesthesia (two-step anesthesia) for intravitreal injection #TAIVI# vs topical anesthesia
Detailed description
Purpose: Patient pain for intravitreal injection is evaluated between topical anesthesia combined sub-conjunctival anesthesia (two-step anesthesia) and topical anesthesia. Methods: This prospective, randomized, single-blinded clinical trail is conducted at Shanghai Aier Eye Hospital. Selected group of 60 patients will be randomized divided into 2 groups and underwent intravitreal injection of antiangiogenic agents and steroids. Group1 uses two-step anesthesia , whereas Group 2 uses topical anesthesia. A 5-point Visual Analogue Pain Scale is used to assess patients' pain score and surgeon's ease while operating. Any complications therefore will be made note of.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Two step anesthesia | conjunctival cul-de-sac anesthetized with 0.5% proparacaine hydrochloride drops three times + 2% lidocaine 0.2 ml subconjunctival injection |
| PROCEDURE | topical anesthesia | conjunctival cul-de-sac anesthetized with 0.5% proparacaine hydrochloride drops three times |
Timeline
- Start date
- 2019-03-08
- Primary completion
- 2019-09-11
- Completion
- 2020-01-01
- First posted
- 2019-03-12
- Last updated
- 2019-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03871062. Inclusion in this directory is not an endorsement.